X4 Pharmaceuticals (XFOR) Misses Q1 EPS by 12c

X4 Pharmaceuticals (NASDAQ: XFOR) reported Q1 EPS of ($0.26), $0.12 worse than the analyst estimate of ($0.14).

For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.

You May Also Be Interested In

• Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating
• Azitra, Inc. (AZTR) Tops Q2 EPS by 54c
• Innovative Solutions & Support (ISSC) Tops Q3 EPS by 10c